Short-Term Comparison of Switching to Brolucizumab or Faricimab from Aflibercept in Neovascular AMD Patients
<i>Background and Objectives</i>: In this study, our objective was to assess and compare the changes in visual and structural outcomes among patients with neovascular age-related macular degeneration (nAMD) who were switched from intravitreal aflibercept (IVA) to either intravitreal brolucizumab (IV...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2024-07-01
|
| Серія: | Medicina |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/1648-9144/60/7/1170 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|